Skip to main navigation
Decibel Therapeutics logo
Menu Button

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

Press Releases

February 24, 2021
Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations

more

February 19, 2021
Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference

more

February 11, 2021
Decibel Therapeutics Announces Pricing of Initial Public Offering

more

January 29, 2021
Decibel Therapeutics and Invitae Announce Launch of Amplify™ Genetic Testing Program

more

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2021. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us